MXC.AX - MGC Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 547.32M
Enterprise value 344.81M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)72.11
Price/book (mrq)4.33
Enterprise value/revenue 368.28
Enterprise value/EBITDA 6-5.30

Trading information

Stock price history

Beta (3Y monthly) 2.74
52-week change 3-18.75%
S&P500 52-week change 32.49%
52-week high 30.0810
52-week low 30.0320
50-day moving average 30.0444
200-day moving average 30.0475

Share statistics

Avg vol (3-month) 32.39M
Avg vol (10-day) 33.38M
Shares outstanding 51.21B
Float 1.06B
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 210/1
Last split date 321 Aug. 2012

Financial highlights

Fiscal year

Fiscal year ends 30 Jun. 2019
Most-recent quarter (mrq)30 Jun. 2019

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,327.51%

Management effectiveness

Return on assets (ttm)-33.01%
Return on equity (ttm)-16.21%

Income statement

Revenue (ttm)656.24k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)299.6k
EBITDA -8.45M
Net income avi to common (ttm)-1.86M
Diluted EPS (ttm)-0.0020
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.35M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)1.71
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-6.35M
Levered free cash flow (ttm)-9.26M